Eukaryotic translation initiation factor 4B pseudogene 9 (EIF4BP9)

Eukaryotic translation initiation factor 4B pseudogene 9 (EIF4BP9) is an annotated human pseudogene and not an active protein-coding gene or functional receptor, enzyme, transporter, or translation factor. It represents a genomic DNA sequence with strong similarity to the gene encoding eukaryotic translation initiation factor 4B (EIF4B), but it is predicted to be non-functional: it does not encode a functional protein owing to genetic mutations, truncations, or lack of critical regulatory elements. Pseudogenes like EIF4BP9 do not perform biological functions, are not known to play roles in disease, and are not considered drug targets or biomarkers. No drugs are known to interact with EIF4BP9, and there are no safety concerns or mechanism-of-action data related to this pseudogene. Key context: - Active translation initiation factors include proteins such as EIF4B, EIF4E, and EIF4A, which are involved in the mRNA translation process[1][3]. - Pseudogenes are “defunct” relatives of known protein-coding genes, often arising from duplication or retrotransposition events. EIF4BP9 is one such pseudogene for EIF4B. - There is no evidence EIF4BP9 is expressed as an RNA or protein, nor is there literature suggesting any therapeutic or biomarker relevance. Summary: EIF4BP9 is a pseudogene (non-coding, non-functional), not a drug target, and therefore most requested fields such as biological functions, interacting drugs, and disease roles are not applicable. If you are interested in the active protein, refer to "Eukaryotic translation initiation factor 4B" (EIF4B), not EIF4BP9.